Patent Expiry

Patent/Exclusivity Expiry: WAKIX

Drug
WAKIX

Other upcoming events for HRMY

Phase 3 ReadoutPhase 3 Topline: A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydr
Phase 3 ReadoutPhase 3 Topline: Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Thera

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar